Core Points - Weigao Blood Products (603014) experienced a 4.02% increase in stock price with a turnover rate of 46.10% and a trading volume of 770 million yuan, indicating significant market activity [2] - The stock was listed on the Shanghai Stock Exchange due to its high turnover rate, with a net selling amount of 16.03 million yuan from brokerage seats [2] - The company reported a revenue of 1.765 billion yuan for the first half of the year, reflecting an 8.52% year-on-year growth, and a net profit of 220 million yuan, which is a 10.11% increase compared to the previous year [2] Trading Activity - The top buying brokerage was Huaxin Securities with a purchase amount of 35.66 million yuan, while the largest selling brokerage was CITIC Securities with a selling amount of 60.07 million yuan [2] - The total trading volume from the top five buying and selling brokerages amounted to 263 million yuan, with a net selling of 16.03 million yuan [2] - The stock saw a net inflow of 101 million yuan from main funds today, with a significant inflow of 107 million yuan from large orders [2]
威高血净龙虎榜数据（9月2日）